Progressive Resistance Training in Head and Neck Cancer Patients During Concomitant Chemoradiotherapy
Progressive Resistance Training in Head and Neck Cancer Patients During Concomitant Chemoradiotherapy - The DAHANCA 31 Study
Sponsor: Aarhus University Hospital
Terminated
Slow recruition
Other terminated trials from Aarhus University Hospital
Other Head and Neck Neoplasms trials with similar outcome
Listed as NCT02557529, this NA trial focuses on Head and Neck Neoplasms and Weight Loss and remains terminated or withdrawn. Sponsored by Aarhus University Hospital, it has been updated 7 times since 2015, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jun 2020 — Jan 2021 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Dec 2019 — Jun 2020 [monthly]
Recruiting NA
Status: Unknown Status → Recruiting · Phase: PHASE2 → NA
▶ Show 2 earlier versions
-
Jun 2018 — Dec 2019 [monthly]
Unknown Status PHASE2
Status: Recruiting → Unknown Status
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE2
First recorded
Aug 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Aarhus University Hospital
- Danish Head and Neck Cancer Group
- Herlev Hospital
- Odense University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .